<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20180825040859N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-01-16</date_registration>
      <primary_sponsor>Boushehr University of Medical Sciences</primary_sponsor>
      <public_title>Evaluation of the effect of localized Lidocaine Injection  on post-tansilectomy pain</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of the effect of local injection of Lidocain on post-tansilectomy pain in children aged 5 -12 years old</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-01-30</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>134</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/33498</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Among the patients referring to the elective tansillectomy, the population of the sample was selected as simple sampling based on the satisfaction of the company in the study. For random allocation, the participants were divided into two groups of intervention (lidocaine receptor) and control group (normal saline recipients) using four balanced blocks. Random sequence generation is done using Excel software and the size of all blocks is equal. To blind patients after describing the goals of the study and obtain written consent for participation in the study, participants are divided  into intervention recipient groups and control groups without any knowledge of the patient of the type of intervention  by block method (by assigning different codes). After performing the intervention by the researcher, to assess the severity of pain in patients, the outcome evaluator was not aware of the type of intervention performed and evaluated the patients with the assigned codes. When analyzing data, the data analyzer does not know the partitioning of the groups and the codes assigned to them, and the comparisons are performed under two unspecified groups, Blinding description: In this study, only the surgeon (project executive) knew the type of intervention and patients, the person assessing the severity of pain and the person analyzing the information, are not aware of the type of intervention  group or control group. To blind patients after describing the goals of the study and obtain written consent for participation in the study, participants are divided  into intervention recipient groups and control groups without any knowledge of the patient of the type of intervention  by block method (by assigning different codes). After performing the intervention by the researcher, to assess the severity of pain in patients, the outcome evaluator was not aware of the type of intervention performed and evaluated the patients with the assigned codes. When analyzing data, the data analyzer does not know the partitioning of the groups and the codes assigned to them, and the comparisons are performed under two unspecified groups.</study_design>
      <phase>3</phase>
      <hc_freetext>Pain control after tonsillectomy.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group:  before tonsillectomy, once  using lidocaine ampoule of 20 mg/ml from Darou Pakhsh company, will be injected at the dose of 1 mg/kg in the tonsillar bed. Intervention 2: Control group: Before tansillectomy , 2 cc normal saline will be injected as a placebo in the tonsillar bed.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Yes, the title of the study and how the study is carried out will be published in the form of medical ethics once the results of the study are published

When:
Yes, the data will become available 3 months after the results are printed

To whom:
Yes, after the study is completed, data will be available for academic and research institutes

Conditions:
After the completion of the project, it will be specified

Where to obtain:
Yes, after publishing the results, you can receive documents or data by e-mail mosaddegh.med@gmail.com or phone number 00989178744511 (Ali Mossadegh).

How to obtain:
The release plan is still unknown

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Ali Mosaddegh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahid Keshtekar Ave, Khoshab Village, Borazjan Town</address>
        <city>Borazjan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7561146551</zip>
        <telephone>+98 77 3437 2670</telephone>
        <email>mosaddegh.med@gmail.com</email>
        <affiliation>Boushehr University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Allahkaram Akhlaghi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>unit 16, Fatemeh Al Zahra Doctors' Hospital, Moallem Squ</address>
        <city>Bushehr</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7517933755</zip>
        <telephone>+98 77 3332 9190</telephone>
        <email>akhlaghidr@gmail.com</email>
        <affiliation>Boushehr University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age between 5-12 year's old
Chronic tonsillitis or recurrent tonsillitis
Peritonsillar abscess
Tonsillogenic septicemia
Focal symptoms following tonsillitis
Severe tonsil hypertrophy causing mechanical obstruction
Suspicious to tonsil tumor
Resistant carriers of diphtheria bacilli
Bad and resistant mouth odor due to the high production of tonsillar plaques
Tuberculous lymphadenitis, in which the tonsils are possible entry point</inclusion_criteria>
      <agemin>5 years</agemin>
      <agemax>12 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Metabolic disorders
Coagulopathy
Mental retardation
Developmental dysfunction
Drug allergy
Psychotic disorders
Chronic pain and those who received analgesic
Heart patients
Disagreement of the parents with their child's participation in the study</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>J35.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Hypertrophy of tonsils</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:  before tonsillectomy, once  using lidocaine ampoule of 20 mg/ml from Darou Pakhsh company, will be injected at the dose of 1 mg/kg in the tonsillar bed.</i_keyword>
      <i_keyword>Control group: Before tansillectomy , 2 cc normal saline will be injected as a placebo in the tonsillar bed.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Post  tonsillectomy  pain based on Children's Hospital of Eastern Ontario Pain Scale. Timepoint: In the minutes 15, 30, 60, 120, 240, 360 after tonsillectomy. Method of measurement: Children's Hospital of Eastern Ontario Pain Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Boushehr University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-08-21</approval_date>
        <contact_name>Ethics committee of Bushehr University of Medical Sciences</contact_name>
        <contact_address>Bushehr University of Medical Sciences, Salman Farsi Ave, Rishehr, Bushehr Bushehr Boushehr Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
